International >>
Home / Press / Corporate /   

Contact Information

Adrienne Bavar
Shop PR
(212) 829-1111 x 191
adrienne@shop-pr.com

Erin McNally
Shop PR
(212) 829-1111 x192
erin@shop-pr.com


PRESS RELEASES

<< Return to press list

SkinMedica Launches New Hyperpigmentation System
Includes Rx EpiQuin® Micro

Carlsbad, Calif. - May 18, 2007 - SkinMedica, Inc., launches their first Hyperpigmentation System to address the growing skincare concern for consumers. Designed to improve visible signs of aging by evening out skin tone, this system utilizes core products from the SkinMedica® line including TNS Recovery Complex® and EpiQuin® Micro (Rx only), the only hydroquinone 4% formulated with Microsponge® technology.

The TNS Hyperpigmentation System recaptures the smooth, firm and glowing look of young healthy skin. The low irritation system is formulated for all skin types (I – IV) and is the ultimate way to to improve the visible signs of skin aging – hyperpigmentation, melasma, photodamage, fine lines, wrinkles and sallowness. The products are sold in an easy-to-use kit arranged in order of use. The kit also includes luxury sample size enhancement products and a regimen bag. For optimal results, use in conjunction with the SkinMedica Vitalize Peel®.

SkinMedica, Inc. is an aesthetic and pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases.

###

CONTACT INFORMATION: Ted Schwarz Vice President, Aesthetic Division SkinMedica, Inc. (760) 448-3600 www.skinmedica.com

About SkinMedica
SkinMedica is a privately held specialty pharmaceutical company marketing both prescription and cosmeceutical dermatology products. SkinMedica's Desonate™ (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin® Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA® (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz® Micro Cream and NeoBenz® Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of cosmeceutical products, which is sold through physicians, includes TNS Recovery Complex® with NouriCel-MD® to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit www.skinmedica.com.

SkinMedica®, Desonate™, EpiQuin® Micro, NeoBenz® Micro, NouriCel-MD®, TNS Recovery Complex®, and VANIQA® are registered trademarks of SkinMedica, Inc.

Copyright © 2008 SkinMedica, Inc. All rights reserved.  privacy / terms of use
A note to the viewer: The products described on this webpage meet the FDA's definition of a cosmetic product and are intended to clean, beautify, promote attractiveness or alter your appearance. These statements have not been evaluated by the FDA. These products are not intended to be drug products that diagnose, treat, cure or prevent any disease or condition